参考文献 1. Denning DW. Invasive aspergillosis. Clin Infect Dis, 1998, 26(4): 781-803. 2. Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis, 2002, 21(3): 161-172. 3. Beauvais A, Schmidt C, Guadagnini S, et al. An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus. Cell Microbiol, 2007, 9(6): 1588-1600. 4. Loussert C, Schmitt C, Prevost MC, et al. In vivo biofilm composition of Aspergillus fumigatus. Cell Microbiol, 2010, 12(3): 405-410. 5. Costerton JW, Lewandowski Z, Caldwell DE, et al. Microbial biofilms. Annu Rev Microbiol, 1995, 49(1): 711-745. 6. Ramage G, Vandewalle K, Wickes BL, et al. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol, 2001, 18(4): 163-170. 7. Ramage G, Saville SP, Thomas DP, et al. Candida biofilms: an update. Eukaryot Cell, 2005, 4(4): 633-638. 8. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved standard-Second Edition. CLSI document M38-A2. CLSI, Wayne, Pa, USA, 2008. 9. Pierce CG, Uppuluri P, Tristan AR, et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc, 2008, 3(9): 1494-1500. 10. Mowat E, Butcher J, Lang S, et al. Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. J Med Microbiol, 2007, 56(Pt 9): 1205-1212. 11. Ramadan G, Davies B, Kurup VP, et al. Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen. Clin Exp Immunol, 2005, 139(2): 257-267. 12. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res, 2001, 29(9): 2002-2007. 13. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis, 2008, 46(3): 327-360. 14. Howard SJ, Webster I, Moore CB, et al. Multi-azole resistance in Aspergillus fumigatus. Int J Antimicrob Agents, 2006, 28(5): 450-453. 15. Chamilos G, Kontoyiannis DP. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Drug Resist Updat, 2005, 8(6): 344-358. 16. da Silva Ferreira ME, Capellaro JL, dos Reis Marques E, et al. In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance. Antimicrob Agents Chemother, 2004, 48(11): 4405-4413. 17. Nascimento AM, Goldman GH, Park S, et al. Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob Agents Chemother, 2003, 47(5): 1719-1726. 18. Slaven JW, Anderson MJ, Sanglard D, et al. Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genet Biol, 2002, 36(3): 199-206. 19. Tobin MB, Peery RB, Skatrud PL. Genes encoding multiple drug resistance-like proteins in Aspergillus fumigatus and Aspergillus flavus. Gene, 1997, 200(1-2): 11-23. |